Akcea Therapeutics Turns to The Chase Group to Secure Chief Medical Officer

April 29, 2020
Akcea Therapeutics is focused on helping patients living with rare diseases by understanding patient and physician needs by bringing transformative medicines to market. Akcea is currently seeking a seasoned Chief Medical Officer to join their executive management team and has retained The Chase Group for their expertise in life science executive search. TCG will identify and secure the high caliber talent required to drive the strategic direction, planning, and execution of Akcea’s late-phase clinical development programs and their commercial product portfolio. For more information, please contact karen@chasegroup.com

Chase Group

Share this Content

Copyright © 1993-2024 The Chase Group. All Rights Reserved.